BioNote Statistics

Total Valuation

BioNote has a market cap or net worth of KRW 474.05 billion. The enterprise value is 61.28 billion.

Market Cap	474.05B
Enterprise Value	61.28B

Important Dates

The last earnings date was Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

BioNote has 102.06 million shares outstanding. The number of shares has increased by 4.14% in one year.

Current Share Class	n/a
Shares Outstanding	102.06M
Shares Change (YoY)	+4.14%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	61.10%
Owned by Institutions (%)	0.18%
Float	11.74M

Valuation Ratios

The trailing PE ratio is 5.81.

PE Ratio	5.81
Forward PE	n/a
PS Ratio	4.99
PB Ratio	0.30
P/TBV Ratio	n/a
P/FCF Ratio	11.04
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.72, with an EV/FCF ratio of 1.43.

EV / Earnings	0.75
EV / Sales	0.64
EV / EBITDA	2.72
EV / EBIT	4.25
EV / FCF	1.43

Financial Position

The company has a current ratio of 25.93, with a Debt / Equity ratio of 0.00.

Current Ratio	25.93
Quick Ratio	24.41
Debt / Equity	0.00
Debt / EBITDA	0.17
Debt / FCF	0.09
Interest Coverage	21.31

Financial Efficiency

Return on equity (ROE) is 5.31% and return on invested capital (ROIC) is 0.58%.

Return on Equity (ROE)	5.31%
Return on Assets (ROA)	0.56%
Return on Capital (ROIC)	0.58%
Revenue Per Employee	319.06M
Profits Per Employee	274.00M
Employee Count	n/a
Asset Turnover	0.06
Inventory Turnover	1.73

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +15.26% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+15.26%
50-Day Moving Average	4,622.90
200-Day Moving Average	4,393.43
Relative Strength Index (RSI)	49.61
Average Volume (20 Days)	134,691

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioNote had revenue of KRW 95.08 billion and earned 81.65 billion in profits. Earnings per share was 798.94.

Revenue	95.08B
Gross Profit	46.88B
Operating Income	14.41B
Pretax Income	25.78B
Net Income	81.65B
EBITDA	22.52B
EBIT	14.41B
Earnings Per Share (EPS)	798.94

Full Income Statement

Balance Sheet

The company has 416.70 billion in cash and 3.93 billion in debt, giving a net cash position of 412.77 billion or 4,044.54 per share.

Cash & Cash Equivalents	416.70B
Total Debt	3.93B
Net Cash	412.77B
Net Cash Per Share	4,044.54
Equity (Book Value)	1.59T
Book Value Per Share	15,543.68
Working Capital	449.05B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 50.55 billion and capital expenditures -7.62 billion, giving a free cash flow of 42.93 billion.

Operating Cash Flow	50.55B
Capital Expenditures	-7.62B
Free Cash Flow	42.93B
FCF Per Share	420.65

Full Cash Flow Statement

Margins

Gross margin is 49.30%, with operating and profit margins of 15.16% and 85.88%.

Gross Margin	49.30%
Operating Margin	15.16%
Pretax Margin	27.11%
Profit Margin	85.88%
EBITDA Margin	23.68%
EBIT Margin	15.16%
FCF Margin	45.15%

Dividends & Yields

BioNote does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	25.00%
Buyback Yield	-4.14%
Shareholder Yield	-4.14%
Earnings Yield	17.20%
FCF Yield	9.06%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioNote has an Altman Z-Score of 7.12.

Altman Z-Score	7.12
Piotroski F-Score	n/a